These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 1942766)
1. Doses of endothelin have natriuretic effects in conscious rats with cirrhosis and ascites. Clària J; Jiménez W; Arroyo V; Castro A; Asbert M; Ros J; Rivera F; Rodés J Kidney Int; 1991 Aug; 40(2):182-7. PubMed ID: 1942766 [TBL] [Abstract][Full Text] [Related]
2. Renal effects of atrial natriuretic peptide in cirrhotic rats with and without captopril pretreatment. Brunkhorst R; Wrenger E; Malcharzik C; Brabant G; Koch KM Nephron; 1993; 64(2):275-81. PubMed ID: 8321362 [TBL] [Abstract][Full Text] [Related]
3. Acute effects of the oral administration of midodrine, an alpha-adrenergic agonist, on renal hemodynamics and renal function in cirrhotic patients with ascites. Angeli P; Volpin R; Piovan D; Bortoluzzi A; Craighero R; Bottaro S; Finucci GF; Casiglia E; Sticca A; De Toni R; Pavan L; Gatta A Hepatology; 1998 Oct; 28(4):937-43. PubMed ID: 9755229 [TBL] [Abstract][Full Text] [Related]
4. Role of altered systemic hemodynamics in the blunted renal response to atrial natriuretic peptide in rats with cirrhosis and ascites. López C; Jiménez W; Arroyo V; La Villa G; Gaya J; Clària J; Rivera F; Rodés J J Hepatol; 1989 Sep; 9(2):217-26. PubMed ID: 2530268 [TBL] [Abstract][Full Text] [Related]
5. Increased natriuretic efficiency of furosemide in rats with carbon tetrachloride-induced cirrhosis. Jonassen TE; Sørensen AM; Petersen JS; Andreasen F; Christensen S Hepatology; 2000 Jun; 31(6):1224-30. PubMed ID: 10827146 [TBL] [Abstract][Full Text] [Related]
6. Atrial natriuretic peptide in rats with experimental cirrhosis of the liver without ascites. Olivera A; Gutkowska J; Rodriguez-Puyol D; Fernandez-Cruz A; López-Novoa JM Endocrinology; 1988 Mar; 122(3):840-6. PubMed ID: 2963741 [TBL] [Abstract][Full Text] [Related]
7. Effect of atrial natriuretic peptide on arterial pressure and renal function in cirrhotic rats with ascites. López C; Jiménez W; Arroyo V; Gaya J; Rivera F; Rodés J Rev Esp Fisiol; 1988 Sep; 44(3):265-72. PubMed ID: 2976517 [TBL] [Abstract][Full Text] [Related]
8. Cannabinoid type 1 receptor antagonism delays ascites formation in rats with cirrhosis. Domenicali M; Caraceni P; Giannone F; Pertosa AM; Principe A; Zambruni A; Trevisani F; Croci T; Bernardi M Gastroenterology; 2009 Jul; 137(1):341-9. PubMed ID: 19208344 [TBL] [Abstract][Full Text] [Related]
9. [Renal tubular function in cirrhotic patients with ascites: special reference to lithium clearance following the human atrial natriuretic peptide administration]. Ando M Nihon Jinzo Gakkai Shi; 1991 Aug; 33(8):791-801. PubMed ID: 1837568 [TBL] [Abstract][Full Text] [Related]
10. Effects of long-term administration of octreotide on sodium retention and atrial natriuretic peptide in carbon tetrachloride-induced cirrhotic rats. Wang SS; Lee FY; Wu SL; Hwu CM; Chien CH; Lee SD; Tsai YT; Chao Y; Chen CC; Wang PS J Hepatol; 1997 May; 26(5):1128-34. PubMed ID: 9186844 [TBL] [Abstract][Full Text] [Related]
11. Haemodynamic effects of angiotensin II in conscious, non-ascitic cirrhotic rats. Fernández-Muñoz MD; Villamediana LM; Blanchart A; Caramelo C; Hernando L; López-Novoa JM Clin Physiol Biochem; 1988; 6(1):36-43. PubMed ID: 3282751 [TBL] [Abstract][Full Text] [Related]
13. Blunted natriuretic response to human urine extracts with Na+,K(+)-ATPase inhibiting activity in experimental cirrhosis. Asbert M; Clària J; Jiménez W; Arroyo V; Ros J; Gaya J; Rivera F; Rodés J J Hepatol; 1994 May; 20(5):660-5. PubMed ID: 8071545 [TBL] [Abstract][Full Text] [Related]
14. [Renal effects of the chronic inhibition of nitric oxide synthesis in cirrhotic rats with ascites]. Ortiz MC; Fortepiani LA; Martínez-Salgado C; Eleno N; Atucha NM; López-Novoa JM; García-Estañ J Nefrologia; 2001; 21(6):556-64. PubMed ID: 11881425 [TBL] [Abstract][Full Text] [Related]
15. Possible role of endothelin acting within the hypothalamus to induce the release of atrial natriuretic peptide and natriuresis. Antunes-Rodrigues J; Ramalho MJ; Reis LC; Picanco-Diniz DW; Favaretto AL; Gutkowska J; McCann SM Neuroendocrinology; 1993 Dec; 58(6):701-8. PubMed ID: 8127397 [TBL] [Abstract][Full Text] [Related]
16. Renal nerves mediate blunted natriuresis to atrial natriuretic peptide in cirrhotic rats. Koepke JP; Jones S; DiBona GF Am J Physiol; 1987 May; 252(5 Pt 2):R1019-23. PubMed ID: 2953257 [TBL] [Abstract][Full Text] [Related]
17. Increased activity of guanosine 3'-5'-cyclic monophosphate phosphodiesterase in the renal tissue of cirrhotic rats with ascites. Angeli P; Jiménez W; Veggian R; Fasolato S; Volpin R; MacHenzie HS; Craighero R; Libera VD; Sticca A; Arroyo V; Gatta A Hepatology; 2000 Feb; 31(2):304-10. PubMed ID: 10655250 [TBL] [Abstract][Full Text] [Related]
18. Effects of repeated atrial natriuretic peptide bolus injections in cirrhotic patients with refractory ascites. Laffi G; Marra F; Pinzani M; Meacci E; Tosti-Guerra C; De Feo ML; Gentilini P Liver; 1989 Dec; 9(6):315-21. PubMed ID: 2532698 [TBL] [Abstract][Full Text] [Related]
19. Effect of V1-vasopressin receptor blockade on arterial pressure in conscious rats with cirrhosis and ascites. Claria J; Jiménez W; Arroyo V; La Villa G; López C; Asbert M; Castro A; Gaya J; Rivera F; Rodés J Gastroenterology; 1991 Feb; 100(2):494-501. PubMed ID: 1824629 [TBL] [Abstract][Full Text] [Related]
20. Impairment of renal function during moderate physical exercise in cirrhotic patients with ascites: relationship with the activity of neurohormonal systems. Saló J; Guevara M; Fernández-Esparrach G; Bataller R; Ginès A; Jimenez W; Ginès P; Rivera F; Arroyo V; Rodés J Hepatology; 1997 Jun; 25(6):1338-42. PubMed ID: 9185749 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]